Deep Track Capital, LP 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:27 am Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 3,282,000 3.270% |
1,282,000 (+64.10%) |
Filing |
| 2024-02-14 08:39 am Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,000,000 3.260% |
-2,500,000 (-55.56%) |
Filing |
| 2024-01-19 4:38 pm Purchase |
2024-01-11 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 4,500,000 5.550% |
2,500,000 (+125.00%) |
Filing |
| 2024-01-19 09:08 am Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,000,000 3.260% |
-684,200 (-25.49%) |
Filing |
| 2023-02-14 08:32 am Sale |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,684,200 5.150% |
-132,750 (-4.71%) |
Filing |
| 2022-01-20 4:27 pm Purchase |
2022-01-18 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,816,950 5.470% |
2,816,950 (New Position) |
Filing |